6,7-Dimethoxy-3,4-dihydroisoquinolin-1(2H)-ylidenoacetonitrile in some fusion reactions
摘要:
6,7-Dimethoxy-3,4-dihydroisoquinolin-1-ylacetonitrile in the enamine form readily reacts with acyl iso(thio)cyanates affording in high yields 1,2-fused oxo- and thioxodihydropyrimidoisoquinolines and thiouracyloisoquinolines. The reaction of the enamine with primary amines of diverse classes in the presence of 2 equiv of formaldehyde resulted in 1,2-fused N-substituted tetrahydropyrimidinoisoquinolines whose yields depended on the basicity and sterical accessibility of the reagent. Fused 5-hydroxyindolo-, dioxopyrrolo-, pyrroloisoquinolines formed in medium yields in the one-stage reactions of the enamine with p-benzoquinone, oxalyl chloride, and beta-nitrostyrene respectively. The reaction of 1-cyanomethyl-6,7-dimethoxydihydroisoquinoline with acrylonitrile leads to the formation of 1,2-fused iminopyridinoisoquinoline easily hydrolysable to pyridine derivative and readily reacting by the amidine group with aroyl chlorides and arylsulfonyl chlorides.
[3+3] Cyclization reactions of β-nitroenamines and β-enaminonitriles with α,β-unsaturated carboxylic acid chlorides
作者:Mihály V. Pilipecz、Tamás R. Varga、Zoltán Mucsi、Pál Scheiber、Péter Nemes
DOI:10.1016/j.tet.2008.03.090
日期:2008.6
New indolizidines, quinolizidines, and octahydro-pyrido[1,2-a]azepines of lactam type were synthesized from 2-nitromethylene-pyrrolidine, -piperidine, and -hexahydroazepine, respectively, by [3+3] cyclizations with α,β-unsaturatedcarboxylicacidchlorides. In the case of quinolizidines, a double bond migration was observed, and explained in terms of amidity percentage. Cyanomethylene-pyrrolidine gave
通过[3 + 3]与α,β-的环化反应,分别由2-硝基亚甲基-吡咯烷,-哌啶和-六氢a庚啶合成了内酰胺型的新吲哚并咪唑,喹唑烷和八氢吡啶并[1,2- a ]氮杂ze。不饱和羧酸氯化物。在喹喔啉类的情况下,观察到双键迁移,并且用酰胺百分比来解释。当分别使用简单的开链酰基氯或肉桂酰氯时,氰基亚甲基-吡咯烷产生内酰胺类型的吲哚并咪唑,而1-氰基亚甲基-四氢异喹啉的转化产生内酰胺和酮。
SMALL MOLECULE INHIBITORS OF VIRAL PROTEIN INTERACTIONS WITH HUMAN T-RNA
申请人:Sirga Advanced Biopharma, Inc.
公开号:US20150190384A1
公开(公告)日:2015-07-09
Disclosed herein are compounds, compositions and methods of their use to treat HIV/AIDS disease in a subject in need thereof wherein the compositions comprise small molecule inhibitors that inhibit viral preparation or viral recruitment of human tRNA3Lys.
US9775835B2
申请人:——
公开号:US9775835B2
公开(公告)日:2017-10-03
[EN] SMALL MOLECULE INHIBITORS OF VIRAL PROTEIN INTERACTIONS WITH HUMAN T-RNA<br/>[FR] INHIBITEURS À PETITES MOLÉCULES DES INTERACTIONS DES PROTÉINES VIRALES AVEC L'ARNT HUMAIN
申请人:SIRGA ADVANCED BIOPHARMA INC
公开号:WO2014025749A2
公开(公告)日:2014-02-13
Disclosed herein are compounds, compositions and methods of their use to treat HIV/AIDS disease in a subject in need thereof, wherein the compositions comprise small molecule inhibitors that inhibit viral preparation or viral recruitment of human tRNA3Lys.